← Leaderboards
Brian J Bacskai
Massachusetts General Hospital
$26,389,294
Attributed
$31,061,861
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.1M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,061,861 · 12
By mechanism
R01$23,558,490 · 7
RF1$6,407,736 · 2
R56$598,020 · 1
S10$491,520 · 1
U41$6,095 · 1
Top collaborators
- Steven M Greenberg6 shared
- Dmitry Gerashchenko3 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Guillermo J. Tearney$42,608,505
- Brett E Bouma$16,028,207
- David A Boas$41,142,921
- Benjamin James Vakoc$7,888,946
- Anand Viswanathan$12,542,460
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposBrainMouse ModelS DiseaseImageStructureNeuronsIn VivoSenile PlaquesAmyloidMicroscopyPreventReporterLifeDepositionFunctional DisorderDisease ProgressionPathologyAmyloid Beta-ProteinCellsTissuesMonitorDetectionTransgenic Mice
Grant awards (54)
Astrocytes as governing pathological drivers of neurovascular dysfunction in AD$500,882
R01 · FY2025 · AG · contact PI
Astrocytes as governing pathological drivers of neurovascular dysfunction in AD$511,105
R01 · FY2024 · AG · contact PI
Astrocytes as governing pathological drivers of neurovascular dysfunction in AD$534,105
R01 · FY2023 · AG · contact PI
The role of astrocytes in Alzheimer's disease pathogenesis$459,185
R01 · FY2021 · AG · contact PI
Slow-wave activity as a modifier of the progression of neurodegeneration in Alzheimer's disease$194,995
RF1 · FY2021 · AG
CEREBRAL AMYLOID ANGIOPATHY AND MECHANISMS OF BRAIN AMYLOID ACCUMULATION$1,134,301
R01 · FY2020 · NS
The role of astrocytes in Alzheimer's disease pathogenesis$459,185
R01 · FY2020 · AG · contact PI
Cerebral microvascular lesions and vascular and neuronal networks$50,000
RF1 · FY2020 · NS · contact PI
Slow-wave activity as a modifier of the progression of neurodegeneration in Alzheimer's disease$2,190,985
RF1 · FY2019 · AG
Slow-wave activity as a modifier of the progression of neurodegeneration in Alzheimer's disease$1,272,239
RF1 · FY2019 · AG
CEREBRAL AMYLOID ANGIOPATHY AND MECHANISMS OF BRAIN AMYLOID ACCUMULATION$1,133,666
R01 · FY2019 · NS
Multiphoton microscopy for in vivo neural imaging$598,020
R56 · FY2019 · AG · contact PI
Molecular pathways leading to neurodegeneration in vivo$467,325
R01 · FY2019 · AG · contact PI
The role of astrocytes in Alzheimer's disease pathogenesis$459,185
R01 · FY2019 · AG · contact PI
Cerebral microvascular lesions and vascular and neuronal networks$2,699,517
RF1 · FY2018 · NS · contact PI
CEREBRAL AMYLOID ANGIOPATHY AND MECHANISMS OF BRAIN AMYLOID ACCUMULATION$1,133,666
R01 · FY2018 · NS
Molecular pathways leading to neurodegeneration in vivo$467,325
R01 · FY2018 · AG · contact PI
The role of astrocytes in Alzheimer's disease pathogenesis$459,185
R01 · FY2018 · AG · contact PI
CEREBRAL AMYLOID ANGIOPATHY AND MECHANISMS OF BRAIN AMYLOID ACCUMULATION$1,133,666
R01 · FY2017 · NS
Molecular pathways leading to neurodegeneration in vivo$475,115
R01 · FY2017 · AG · contact PI
The role of astrocytes in Alzheimer's disease pathogenesis$459,185
R01 · FY2017 · AG · contact PI
CEREBRAL AMYLOID ANGIOPATHY AND MECHANISMS OF BRAIN AMYLOID ACCUMULATION$1,037,212
R01 · FY2016 · NS
Molecular pathways leading to neurodegeneration in vivo$467,325
R01 · FY2016 · AG · contact PI
CEREBRAL AMYLOID ANGIOPATHY AND MECHANISMS OF BRAIN AMYLOID ACCUMULATION$114,404
R01 · FY2016 · NS
Molecular pathways leading to neurodegeneration in vivo$506,685
R01 · FY2015 · AG · contact PI
Multiphoton microscopy for in vivo neural imaging$501,298
R01 · FY2015 · EB · contact PI
Multiphoton microscopy for in vivo neural imaging$496,183
R01 · FY2014 · EB · contact PI
Multiphoton microscopy for in vivo neural imaging$482,374
R01 · FY2013 · EB · contact PI
Multiphoton microscopy for in vivo neural imaging$513,135
R01 · FY2012 · EB · contact PI
Non-invasive optical imaging of neuropathology in vivo$842,241
R01 · FY2010 · AG · contact PI
Multiphoton microscopy for in vivo neural imaging$362,576
R01 · FY2010 · EB · contact PI
Anti-oxidant therapy in Alzheimer's disease$258,785
R01 · FY2010 · AG · contact PI
Non-invasive optical imaging of neuropathology in vivo$825,400
R01 · FY2009 · AG · contact PI
A replacement multiphoton microscope for in vivo imaging in rodent models of neur$491,520
S10 · FY2009 · RR · contact PI
Multiphoton microscopy for in vivo neural imaging$355,569
R01 · FY2009 · EB · contact PI
Anti-oxidant therapy in Alzheimer's disease$261,400
R01 · FY2009 · AG · contact PI
Non-invasive optical imaging of neuropathology in vivo$800,811
R01 · FY2008 · AG · contact PI
Multiphoton microscopy for in vivo neural imaging$345,211
R01 · FY2008 · EB · contact PI
Anti-oxidant therapy in Alzheimer's disease$261,400
R01 · FY2008 · AG · contact PI
Non-invasive optical imaging of neuropathology in vivo$792,619
R01 · FY2007 · AG · contact PI
Multiphoton microscopy for in vivo neural imaging$414,448
R01 · FY2007 · EB · contact PI
Anti-oxidant therapy in Alzheimer's disease$266,734
R01 · FY2007 · AG · contact PI
MULTIPHOTON MICROSCOPY FOR IN VIVO NEURAL IMAGING$6,095
U41 · FY2007 · RR · contact PI
Non-invasive optical imaging of neuropathology in vivo$866,821
R01 · FY2006 · AG · contact PI
Multiphoton microscopy for in vivo neural imaging.$295,636
R01 · FY2006 · EB · contact PI
Mechanisms of amyloid-beta clearance.$280,853
R01 · FY2006 · AG · contact PI
Anti-oxidant therapy in Alzheimer's disease$274,700
R01 · FY2006 · AG · contact PI
Multiphoton microscopy for in vivo neural imaging.$302,750
R01 · FY2005 · EB
Mechanisms of amyloid-beta clearance.$287,613
R01 · FY2005 · AG
Multiphoton microscopy for in vivo neural imaging.$302,750
R01 · FY2004 · EB
Mechanisms of amyloid-beta clearance.$287,613
R01 · FY2004 · AG
Mechanisms of amyloid-beta clearance.$311,363
R01 · FY2003 · AG
Multiphoton microscopy for in vivo neural imaging.$302,750
R01 · FY2003 · EB
Multiphoton microscopy for in vivo neural imaging.$352,750
R01 · FY2002 · EB